204 related articles for article (PubMed ID: 27214789)
1. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investigation of the Cytotoxic Mechanism of Chalcones.
Zhou B; Jiang P; Lu J; Xing C
Arch Pharm (Weinheim); 2016 Jul; 349(7):539-52. PubMed ID: 27214789
[TBL] [Abstract][Full Text] [Related]
2. Unambiguous Identification of β-Tubulin as the Direct Cellular Target Responsible for the Cytotoxicity of Chalcone by Photoaffinity Labeling.
Zhou B; Yu X; Zhuang C; Villalta P; Lin Y; Lu J; Xing C
ChemMedChem; 2016 Jul; 11(13):1436-45. PubMed ID: 27203512
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent cytotoxic ortho-aryl chalcones as new scaffold targeting tubulin and mitosis with affinity-based fluorescence.
Zhu C; Zuo Y; Wang R; Liang B; Yue X; Wen G; Shang N; Huang L; Chen Y; Du J; Bu X
J Med Chem; 2014 Aug; 57(15):6364-82. PubMed ID: 25061803
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.
Halim PA; Hassan RA; Mohamed KO; Hassanin SO; Khalil MG; Abdou AM; Osman EO
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):189-201. PubMed ID: 34894967
[TBL] [Abstract][Full Text] [Related]
13. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a series of tangeretin-derived chalcones.
Quintin J; Desrivot J; Thoret S; Le Menez P; Cresteil T; Lewin G
Bioorg Med Chem Lett; 2009 Jan; 19(1):167-9. PubMed ID: 19013795
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Active Heterocyclic Chalcones: Recent Developments.
Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
18. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
[TBL] [Abstract][Full Text] [Related]
19. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
